Envisia Therapeutics To Present At GTC Bio’s 6th Annual Ocular Diseases & Drug Discovery Conference
3/20/2014 6:47:59 AM
Envisia Therapeutics today announced that it will present data for ENV515, the company’s lead glaucoma product candidate, as well as preliminary data for the company’s novel drug delivery systems designed for the posterior and anterior segments of the eye at the 6th Annual Ocular Diseases and Drug Delivery Conference being held March 20 - 21, 2014 at the Hyatt Regency Mission Bay in San Diego, CA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by